535 related articles for article (PubMed ID: 8558445)
1. Stable expression, pharmacologic properties and regulation of the human neuronal nicotinic acetylcholine alpha 4 beta 2 receptor.
Gopalakrishnan M; Monteggia LM; Anderson DJ; Molinari EJ; Piattoni-Kaplan M; Donnelly-Roberts D; Arneric SP; Sullivan JP
J Pharmacol Exp Ther; 1996 Jan; 276(1):289-97. PubMed ID: 8558445
[TBL] [Abstract][Full Text] [Related]
2. Regulation of human alpha4beta2 neuronal nicotinic acetylcholine receptors by cholinergic channel ligands and second messenger pathways.
Gopalakrishnan M; Molinari EJ; Sullivan JP
Mol Pharmacol; 1997 Sep; 52(3):524-34. PubMed ID: 9281615
[TBL] [Abstract][Full Text] [Related]
3. (S)-3-methyl-5-(1-methyl-2-pyrrolidinyl) isoxazole (ABT 418): a novel cholinergic ligand with cognition-enhancing and anxiolytic activities: I. In vitro characterization.
Arneric SP; Sullivan JP; Briggs CA; Donnelly-Roberts D; Anderson DJ; Raszkiewicz JL; Hughes ML; Cadman ED; Adams P; Garvey DS
J Pharmacol Exp Ther; 1994 Jul; 270(1):310-8. PubMed ID: 7518514
[TBL] [Abstract][Full Text] [Related]
4. Ligand specificity of nicotinic acetylcholine receptors in rat spinal cord: studies with nicotine and cytisine.
Khan IM; Yaksh TL; Taylor P
J Pharmacol Exp Ther; 1994 Jul; 270(1):159-66. PubMed ID: 8035312
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of up-regulation of neuronal nicotinic acetylcholine receptors in clonal cell lines and primary cultures of fetal rat brain.
Bencherif M; Fowler K; Lukas RJ; Lippiello PM
J Pharmacol Exp Ther; 1995 Nov; 275(2):987-94. PubMed ID: 7473192
[TBL] [Abstract][Full Text] [Related]
6. ABT-594 [(R)-5-(2-azetidinylmethoxy)-2-chloropyridine]: a novel, orally effective analgesic acting via neuronal nicotinic acetylcholine receptors: I. In vitro characterization.
Donnelly-Roberts DL; Puttfarcken PS; Kuntzweiler TA; Briggs CA; Anderson DJ; Campbell JE; Piattoni-Kaplan M; McKenna DG; Wasicak JT; Holladay MW; Williams M; Arneric SP
J Pharmacol Exp Ther; 1998 May; 285(2):777-86. PubMed ID: 9580626
[TBL] [Abstract][Full Text] [Related]
7. Characterization of [3H]ABT-418: a novel cholinergic channel ligand.
Anderson DJ; Williams M; Pauly JR; Raszkiewicz JL; Campbell JE; Rotert G; Surber B; Thomas SB; Wasicak J; Arneric SP
J Pharmacol Exp Ther; 1995 Jun; 273(3):1434-41. PubMed ID: 7791118
[TBL] [Abstract][Full Text] [Related]
8. A subtype of nicotinic cholinergic receptor in rat brain is composed of alpha 4 and beta 2 subunits and is up-regulated by chronic nicotine treatment.
Flores CM; Rogers SW; Pabreza LA; Wolfe BB; Kellar KJ
Mol Pharmacol; 1992 Jan; 41(1):31-7. PubMed ID: 1732720
[TBL] [Abstract][Full Text] [Related]
9. Physostigmine and galanthamine: probes for a novel binding site on the alpha 4 beta 2 subtype of neuronal nicotinic acetylcholine receptors stably expressed in fibroblast cells.
Pereira EF; Alkondon M; Reinhardt S; Maelicke A; Peng X; Lindstrom J; Whiting P; Albuquerque EX
J Pharmacol Exp Ther; 1994 Aug; 270(2):768-78. PubMed ID: 8071869
[TBL] [Abstract][Full Text] [Related]
10. [3H]cytisine binding to nicotinic cholinergic receptors in brain.
Pabreza LA; Dhawan S; Kellar KJ
Mol Pharmacol; 1991 Jan; 39(1):9-12. PubMed ID: 1987453
[TBL] [Abstract][Full Text] [Related]
11. Heterologous expression of human {alpha}6{beta}4{beta}3{alpha}5 nicotinic acetylcholine receptors: binding properties consistent with their natural expression require quaternary subunit assembly including the {alpha}5 subunit.
Grinevich VP; Letchworth SR; Lindenberger KA; Menager J; Mary V; Sadieva KA; Buhlman LM; Bohme GA; Pradier L; Benavides J; Lukas RJ; Bencherif M
J Pharmacol Exp Ther; 2005 Feb; 312(2):619-26. PubMed ID: 15356217
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological characterization of SIB-1765F: a novel cholinergic ion channel agonist.
Sacaan AI; Reid RT; Santori EM; Adams P; Correa LD; Mahaffy LS; Bleicher L; Cosford ND; Stauderman KA; McDonald IA; Rao TS; Lloyd GK
J Pharmacol Exp Ther; 1997 Jan; 280(1):373-83. PubMed ID: 8996218
[TBL] [Abstract][Full Text] [Related]
13. ABT-089 [2-methyl-3-(2-(S)-pyrrolidinylmethoxy)pyridine]: I. A potent and selective cholinergic channel modulator with neuroprotective properties.
Sullivan JP; Donnelly-Roberts D; Briggs CA; Anderson DJ; Gopalakrishnan M; Xue IC; Piattoni-Kaplan M; Molinari E; Campbell JE; McKenna DG; Gunn DE; Lin NH; Ryther KB; He Y; Holladay MW; Wonnacott S; Williams M; Arneric SP
J Pharmacol Exp Ther; 1997 Oct; 283(1):235-46. PubMed ID: 9336329
[TBL] [Abstract][Full Text] [Related]
14. alpha4beta2 nicotinic receptors with high and low acetylcholine sensitivity: pharmacology, stoichiometry, and sensitivity to long-term exposure to nicotine.
Moroni M; Zwart R; Sher E; Cassels BK; Bermudez I
Mol Pharmacol; 2006 Aug; 70(2):755-68. PubMed ID: 16720757
[TBL] [Abstract][Full Text] [Related]
15. Functional properties of homomeric, human alpha 7-nicotinic acetylcholine receptors heterologously expressed in the SH-EP1 human epithelial cell line.
Zhao L; Kuo YP; George AA; Peng JH; Purandare MS; Schroeder KM; Lukas RJ; Wu J
J Pharmacol Exp Ther; 2003 Jun; 305(3):1132-41. PubMed ID: 12626641
[TBL] [Abstract][Full Text] [Related]
16. Positive feedback modulation of acetylcholine release from isolated rat superior cervical ganglion.
Liang SD; Vizi ES
J Pharmacol Exp Ther; 1997 Feb; 280(2):650-5. PubMed ID: 9023275
[TBL] [Abstract][Full Text] [Related]
17. Partial agonist properties of cytisine on neuronal nicotinic receptors containing the beta 2 subunit.
Papke RL; Heinemann SF
Mol Pharmacol; 1994 Jan; 45(1):142-9. PubMed ID: 8302273
[TBL] [Abstract][Full Text] [Related]
18. Agonist-induced hump current production in heterologously-expressed human alpha4beta2-nicotinic acetylcholine receptors.
Liu Q; Yu KW; Chang YC; Lukas RJ; Wu J
Acta Pharmacol Sin; 2008 Mar; 29(3):305-19. PubMed ID: 18298895
[TBL] [Abstract][Full Text] [Related]
19. Ablation of primary afferent terminals reduces nicotinic receptor expression and the nociceptive responses to nicotinic agonists in the spinal cord.
Khan IM; Wennerholm M; Singletary E; Polston K; Zhang L; Deerinck T; Yaksh TL; Taylor P
J Neurocytol; 2004 Sep; 33(5):543-56. PubMed ID: 15906161
[TBL] [Abstract][Full Text] [Related]
20. Blockade of rat alpha3beta4 nicotinic receptor function by methadone, its metabolites, and structural analogs.
Xiao Y; Smith RD; Caruso FS; Kellar KJ
J Pharmacol Exp Ther; 2001 Oct; 299(1):366-71. PubMed ID: 11561100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
